FMC is trading 5.1% down at $10.25, extending recent weakness despite the broader market rally on September 17, 2026; no reliable same-day filing, earnings update, downgrade, or adverse announcement explains it.

  • FMC and AgroSpheres announced progress toward global field trials for two bioinsecticide candidates, a positive development not clearly behind today’s selloff.
  • Trading activity was 1.47 million shares versus a 3.33 million average in available market data, indicating lighter-than-average volume.
  • The move remains unexplained; recheck for delayed company news.